Possible Applications for Dopaminergic Agents Following Traumatic Brain Injury: Part 2

This publication has 21 references indexed in Scilit:

• Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice
  Neuroscience Letters, 2000
• Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study
  Brain Injury, 1999
• Case study: Amantadine: a potential treatment for the minimally conscious state
  Brain Injury, 1998
• Ropinirole for the treatment of early Parkinson's disease
  Neurology, 1997
• A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome
  Medical Hypotheses, 1992
• Effects of Long-Term Amantadine Treatment on Clinical Symptoms and EEG of a Patient in a Vegetative State
  Clinical Neuropharmacology, 1990
• A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine D2‐receptor agonist.
  British Journal of Clinical Pharmacology, 1989
• Amantadine for the agitated head-injury patient
  Brain Injury, 1988
• Role of Amantadine in the Management of Neuroleptic-Induced Extrapyramidal Syndromes
  Clinical Neuropharmacology, 1983
• Amantadine in the Treatment of Parkinson's Disease
  JAMA, 1969